Timothy N Wells

Summary

Affiliation: Medicines for Malaria Venture
Country: Switzerland

Publications

  1. ncbi request reprint Discovering and developing new medicines for malaria control and elimination
    Timothy N C Wells
    Medicines for Malaria Venture, ICC, Block G, 3rd Floor, 20 Rue de Pre Bois, PO Box 1826, 1215 Geneva 15, Switzerland
    Infect Disord Drug Targets 13:292-302. 2013
  2. pmc Malaria in South America: a drug discovery perspective
    Luiza R Cruz
    Medicines for Malaria Venture, 20 Route de Pré Bois, Geneva, CH 1215, Switzerland
    Malar J 12:168. 2013
  3. pmc A framework for assessing the risk of resistance for anti-malarials in development
    Xavier C Ding
    Medicines for Malaria Venture, 20 rte de Pré Bois, Geneva CH 1215, Switzerland
    Malar J 11:292. 2012
  4. pmc Designing the next generation of medicines for malaria control and eradication
    Jeremy N Burrows
    Medicines for Malaria Venture MMV, PO Box 1826, Route de Pré Bois 20, Geneva 151215, Switzerland
    Malar J 12:187. 2013
  5. pmc The global pipeline of new medicines for the control and elimination of malaria
    Melinda P Anthony
    Medicines for Malaria Venture MMV, 20 rte de Pré Bois 1215, Geneva, Switzerland
    Malar J 11:316. 2012
  6. pmc Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Timothy N C Wells
    Medicines for Malaria Venture, 20 rte de Pré Bois, CH 1215 Geneva, Switzerland
    Malar J 10:S3. 2011
  7. doi request reprint New medicines to improve control and contribute to the eradication of malaria
    Timothy N C Wells
    Medicines for Malaria Venture, 20 Route de Pré Bois, 1215 Geneva, Switzerland
    Nat Rev Drug Discov 8:879-91. 2009
  8. doi request reprint Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
    Timothy N C Wells
    Medicines for Malaria Venture, Geneva, Switzerland
    Trends Parasitol 26:145-51. 2010
  9. ncbi request reprint When is enough enough? The need for a robust pipeline of high-quality antimalarials
    Timothy N Wells
    Medicines for Malaria Venture, Geneva, Switzerland
    Discov Med 9:389-98. 2010

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Discovering and developing new medicines for malaria control and elimination
    Timothy N C Wells
    Medicines for Malaria Venture, ICC, Block G, 3rd Floor, 20 Rue de Pre Bois, PO Box 1826, 1215 Geneva 15, Switzerland
    Infect Disord Drug Targets 13:292-302. 2013
    ....
  2. pmc Malaria in South America: a drug discovery perspective
    Luiza R Cruz
    Medicines for Malaria Venture, 20 Route de Pré Bois, Geneva, CH 1215, Switzerland
    Malar J 12:168. 2013
    ..This sets the scene for a review of efforts within South America to discover and optimize compounds with anti-malarial activity...
  3. pmc A framework for assessing the risk of resistance for anti-malarials in development
    Xavier C Ding
    Medicines for Malaria Venture, 20 rte de Pré Bois, Geneva CH 1215, Switzerland
    Malar J 11:292. 2012
    ..The integration of this strategy in later stages of development, registration, and deployment is also discussed...
  4. pmc Designing the next generation of medicines for malaria control and eradication
    Jeremy N Burrows
    Medicines for Malaria Venture MMV, PO Box 1826, Route de Pré Bois 20, Geneva 151215, Switzerland
    Malar J 12:187. 2013
    ..Sustained investment over the next decade in discovery and development of new molecules is essential to enable the long-term delivery of the medicines needed to combat malaria...
  5. pmc The global pipeline of new medicines for the control and elimination of malaria
    Melinda P Anthony
    Medicines for Malaria Venture MMV, 20 rte de Pré Bois 1215, Geneva, Switzerland
    Malar J 11:316. 2012
    ..However, there are still risks ahead in clinical development and sustainable funding of clinical studies is vital if this early promise is going to be delivered...
  6. pmc Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Timothy N C Wells
    Medicines for Malaria Venture, 20 rte de Pré Bois, CH 1215 Geneva, Switzerland
    Malar J 10:S3. 2011
    ..It takes ten years to develop a new medicine. New classes of medicines to combat malaria, as a result of infection by Plasmodium falciparum and Plasmodium vivax are urgently needed...
  7. doi request reprint New medicines to improve control and contribute to the eradication of malaria
    Timothy N C Wells
    Medicines for Malaria Venture, 20 Route de Pré Bois, 1215 Geneva, Switzerland
    Nat Rev Drug Discov 8:879-91. 2009
    ....
  8. doi request reprint Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
    Timothy N C Wells
    Medicines for Malaria Venture, Geneva, Switzerland
    Trends Parasitol 26:145-51. 2010
    ..New developments in cell biology are starting to open ways to the next generation of drugs against hypnozoites. This search is urgent, given the time needed to develop a new medication...
  9. ncbi request reprint When is enough enough? The need for a robust pipeline of high-quality antimalarials
    Timothy N Wells
    Medicines for Malaria Venture, Geneva, Switzerland
    Discov Med 9:389-98. 2010
    ..Finally, in order to ultimately eradicate malaria, medicines are needed that go a step beyond simple treatment and break the transmission of the parasite from patient to patient...